PBYI FY 2016 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$299M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$277M

Net Income

-$276M

EPS (Diluted)

$-8.29

Cash Flow

Operating Cash Flow

-$142M

Free Cash Flow

-$149M

Stock-Based Comp.

$117M

Balance Sheet

Total Assets

$253M

Total Liabilities

$43M

Stockholders' Equity

$210M

Cash & Equivalents

$195M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$776,000	-48.1%
Operating Income	-$277M	-$240M	-15.1%
Net Income	-$276M	-$239M	-15.3%